—] Shares QUINTILES TRANSNATIONAL HOLDINGS INC. COMMON STOCK (PAR VALUE $0.01 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • April 26th, 2013 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • New York
INDENTURE Dated as of May 23, 2023 among IQVIA Inc., as Issuer, the Guarantors party hereto, U.S. Bank Trust Company, National Association, as Trustee 6.500% SENIOR NOTES DUE 2030Indenture • May 23rd, 2023 • Iqvia Holdings Inc. • Services-commercial physical & biological research • New York
INDENTURE, dated as of May 23, 2023, among IQVIA Inc., a Delaware corporation, each Guarantor (as defined herein) and U.S. Bank Trust Company, National Association, as Trustee.
Shares QUINTILES TRANSNATIONAL HOLDINGS INC. COMMON STOCK (PAR VALUE $0.01 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • March 10th, 2014 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • New York
RECEIVABLES FINANCING AGREEMENT Dated as of December 5, 2014 by and among QUINTILES FUNDING LLC, as Borrower, THE PERSONS FROM TIME TO TIME PARTY HERETO, as Lenders, PNC BANK, NATIONAL ASSOCIATION, as Administrative Agent, and QUINTILES, INC., as...Receivables Financing Agreement • December 8th, 2014 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • New York
This RECEIVABLES FINANCING AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”) is entered into as of December 5, 2014, by and among the following parties:
CREDIT AGREEMENT Dated as of May 12, 2015 among QUINTILES TRANSNATIONAL CORP. as the Borrower JPMORGAN CHASE BANK, N.A. as Administrative Agent JPMORGAN CHASE BANK, N.A. and MORGAN STANLEY SENIOR FUNDING, INC. as Swing Line Lenders JPMORGAN CHASE...Credit Agreement • May 13th, 2015 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • New York
This CREDIT AGREEMENT (this “Agreement”) is entered into as of May 12, 2015, among Quintiles Transnational Corp., a North Carolina corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, each a “Lender”), and JPMorgan Chase Bank, N.A., as Administrative Agent, a Swing Line Lender and an L/C Issuer.
INDENTURE Dated as of September 28, 2016 among IMS Health Incorporated, as Issuer, the Guarantors party hereto, US Bank National Association, as Trustee 5.000% SENIOR NOTES DUE 2026 3.500% SENIOR NOTES DUE 2024Indenture • October 3rd, 2016 • Quintiles IMS Holdings, Inc. • Services-commercial physical & biological research • New York
INDENTURE, dated as of September 28, 2016, among IMS Health Incorporated, a Delaware corporation, each Guarantor (as defined herein) and U.S. Bank National Association, as Trustee.
QUINTILES TRANSNATIONAL HOLDINGS INC. AWARD AGREEMENT (Awarding Incentive Stock Option)Award Agreement • May 1st, 2014 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • North Carolina
THIS AWARD AGREEMENT (this “Agreement”) is made by and between Quintiles Transnational Holdings Inc., a North Carolina corporation (the “Company”), and [Insert Name of Grantee] (the “Optionee”) pursuant to the provisions of the Quintiles Transnational Holdings Inc. 2013 Stock Incentive Plan (the “Plan”), which is incorporated herein by reference. Capitalized terms not defined in this Agreement shall have the meanings given to them in the Plan.
INDENTURE Dated as of June 24, 2020 among IQVIA Inc., as Issuer, the Guarantors party hereto and U.S. Bank National Association, as Trustee 2.875% SENIOR NOTES DUE 2028Indenture • June 24th, 2020 • Iqvia Holdings Inc. • Services-commercial physical & biological research • New York
INDENTURE, dated as of June 24, 2020, among IQVIA Inc., a Delaware corporation, each Guarantor (as defined herein) and U.S. Bank National Association, as Trustee.
IQVIA HOLDINGS INC. AWARD AGREEMENT (Awarding Stock Appreciation Rights)Award Agreement • May 2nd, 2019 • Iqvia Holdings Inc. • Services-commercial physical & biological research • Delaware
THIS AWARD AGREEMENT (this “Agreement”) is made by and between IQVIA Holdings Inc., a Delaware corporation (the “Company”), and the Participant named above (the “Participant”) pursuant to the provisions of the IQVIA Holdings Inc. 2017 Incentive and Stock Award Plan (as amended from time to time, the “Plan”), which is incorporated herein by reference. Capitalized terms not defined in this Agreement shall have the meanings given to them in the Plan.
INDENTURE Dated as of November 28, 2023 among IQVIA Inc., as Issuer, the Guarantors party hereto and U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent 6.250% SENIOR SECURED NOTES DUE 2029Indenture • November 28th, 2023 • Iqvia Holdings Inc. • Services-commercial physical & biological research • New York
INDENTURE, dated as of November 28, 2023, among IQVIA Inc., a Delaware corporation, each Guarantor (as defined herein) and U.S. Bank Trust Company, National Association, as Trustee and as Collateral Agent.
6,000,000 Shares IQVIA HOLDINGS INC. COMMON STOCK (PAR VALUE $0.01 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • December 4th, 2018 • Iqvia Holdings Inc. • Services-commercial physical & biological research • New York
QUINTILES TRANSNATIONAL HOLDINGS INC. AWARD AGREEMENT (Awarding Nonqualified Stock Option)Award Agreement • February 15th, 2013 • Quintiles Transnational Holdings Inc. • North Carolina
THIS AWARD AGREEMENT (this “Agreement”) is made by and between Quintiles Transnational Holdings Inc., a North Carolina corporation (the “Company”), and Thomas Pike (the “Optionee”) pursuant to the provisions of the Quintiles Transnational Holdings Inc. 2008 Stock Incentive Plan (the “Plan”) and the Optionee’s Executive Employment Agreement, effective April 30, 2012 (the “Executive Employment Agreement”), which is incorporated herein by reference. Capitalized terms not defined in this Agreement shall have the meanings given to them in the Plan.
AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • April 19th, 2013 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research
This AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (“Amendment”) is made and entered into as of the 30 day of DECEMBER, 2008 by and between QUINTILES TRANSNATIONAL CORP., a North Carolina corporation (the “Company”), and JOHN D. RATLIFF (“Executive”).
AMENDMENT NO. 3 TO FIFTH AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • November 28th, 2023 • Iqvia Holdings Inc. • Services-commercial physical & biological research • New York
AMENDMENT NO. 3, dated as of November 28, 2023 (this “Amendment”), among IQVIA Inc., a Delaware corporation (the “Parent Borrower”), IQVIA RDS Inc., a North Carolina corporation and a subsidiary of the Parent Borrower (the “U.S. Borrower”), IQVIA Holdings Inc., a Delaware corporation (“Holdings”), the other guarantors party hereto, Bank of America, N.A., as administrative agent and as collateral agent (in such capacity, the “Administrative Agent”), and the Incremental Term B-4 Dollar Lenders (as defined below).
QUINTILES IMS HOLDINGS, INC. AWARD AGREEMENT (Awarding Restricted Stock Units)Award Agreement • October 3rd, 2016 • Quintiles IMS Holdings, Inc. • Services-commercial physical & biological research • North Carolina
THIS AWARD AGREEMENT (this “Agreement”) is made by and between Quintiles IMS Holdings, Inc., a Delaware corporation (the “Company”), and «Name» (the “Participant”) pursuant to the provisions of the Quintiles IMS Holdings, Inc. 2013 Stock Incentive Plan (the “Plan”), which is incorporated herein by reference. Capitalized terms not defined in this Agreement shall have the meanings given to them in the Plan.
PURCHASE AND SALE AGREEMENT Dated as of December 5, 2014 among VARIOUS ENTITIES LISTED ON SCHEDULE I HERETO, as Originators, QUINTILES, INC., as Servicer, and QUINTILES FUNDING LLC, as BuyerPurchase and Sale Agreement • December 8th, 2014 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • New York
This PURCHASE AND SALE AGREEMENT (as amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), dated as of December 5, 2014, is entered into among the various entities listed on Schedule I hereto or that become parties hereto from time to time pursuant to Section 4.3 hereof (the “Originators” and each, an “Originator”), QUINTILES, INC., as initial Servicer (as defined below) (“QINC”), and QUINTILES FUNDING LLC, a North Carolina limited liability company (the “Buyer”).
SUPPLEMENTAL INDENTURE TO BE DELIVERED BY SUBSEQUENT GUARANTORSIqvia Holdings Inc. • July 22nd, 2024 • Services-commercial physical & biological research • New York
Supplemental Indenture (this “Supplemental Indenture”), dated as of June 27, 2024, among Rules-Based Medicine Inc., a Delaware corporation, Lasso Marketing, Inc., a Delaware corporation and Cognitive Clinical Trials, LLC, a Delaware limited liability company (each a “Guaranteeing Subsidiary”), a subsidiary of IQVIA Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) and as collateral agent (the “Collateral Agent”).
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 15th, 2013 • Quintiles Transnational Holdings Inc. • North Carolina
This Executive Employment Agreement (“Agreement”), dated as of JUNE 1, 2003, is made and entered into by QUINTILES TRANSNATIONAL CORP. a North Carolina corporation (hereinafter the “Company”) and MICHAEL MORTIMER (hereinafter the “Executive”). The Company desires to employ Executive as its EXECUTIVE, VICE PRESIDENT GLOBAL HUMAN RESOURCES and provide adequate assurances to Executive and Executive desires to accept such employment on the terms set forth below, which terms Executive agreed to in Executive’s offer letter.
AGREEMENT AND PLAN OF MERGER by and between IMS HEALTH HOLDINGS, INC. and QUINTILES TRANSNATIONAL HOLDINGS INC. Dated as of May 3, 2016Agreement and Plan of Merger • May 3rd, 2016 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • Delaware
AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of May 3, 2016, by and between IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), and Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”).
IQVIA Holdings Inc. AWARD AGREEMENTAward Agreement • May 2nd, 2019 • Iqvia Holdings Inc. • Services-commercial physical & biological research • Delaware
THIS AWARD AGREEMENT (this “Agreement”) is made by and between IQVIA Holdings Inc., a Delaware corporation (the “Company”), and the Participant named above (the “Participant”) pursuant to the provisions of the IQVIA Holdings Inc. 2017 Incentive and Stock Award Plan (as amended from time to time, the “Plan”), which is incorporated herein by reference. Capitalized terms not defined in this Agreement shall have the meanings given to them in the Plan.
SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, Dated as of May 14, 2013 by and among QUINTILES TRANSNATIONAL HOLDINGS INC. And CERTAIN SHAREHOLDERSRegistration Rights Agreement • May 15th, 2013 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • New York
THIS SECOND AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, dated as of May 14, 2013, by and among Quintiles Transnational Holdings Inc., a North Carolina corporation (the “Company”), and each of the Persons that execute the signature pages hereto under the heading “Shareholders” (each a “Shareholder” and collectively the “Shareholders”).
AMENDMENT NO. 1 TO SHAREHOLDERS AGREEMENTShareholders Agreement • May 14th, 2013 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research
AMENDMENT NO. 1 TO SHAREHOLDERS AGREEMENT, dated as of May 8, 2013, by and among Quintiles Transnational Holdings Inc., a North Carolina corporation (the “Company”), and certain of the Company’s shareholders identified below (the “Amendment”). Capitalized terms used herein but not defined shall have the meaning ascribed to such terms in the Shareholders Agreement (as defined below). Except as provided herein, all other terms, conditions and provisions of the Shareholders Agreement shall remain in full force and effect.
EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • February 12th, 2015 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • North Carolina
This Executive Employment Agreement (“Agreement”) is made and entered into by Quintiles Transnational Corp, a North Carolina corporation (hereinafter the “Company”) and James Erlinger (hereinafter “Executive”). The Company desires to employee Executive as its Executive Vice President, General Counsel and provide adequate assurances to Executive and Executive desires to accept such employment on the terms set forth below.
VOTING AGREEMENTVoting Agreement • May 3rd, 2016 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • Delaware
This VOTING AGREEMENT, dated as of May 3, 2016 (this “Agreement”), among Quintiles Transnational Holdings Inc., a North Carolina corporation (“Quintiles”), and the shareholders of IMS Health Holdings, Inc., a Delaware corporation (“IMS Health”), listed on Schedule A hereto (each, a “Shareholder” and, collectively, the “Shareholders”).
Quintiles IMS HOLDINGS, INC. AWARD AGREEMENTAward Agreement • May 8th, 2017 • Quintiles IMS Holdings, Inc. • Services-commercial physical & biological research • Delaware
THIS AWARD AGREEMENT (this “Agreement”) is made by and between Quintiles IMS Holdings, Inc., a Delaware corporation (the “Company”), and the participant named above (the “Participant”) pursuant to the provisions of the Quintiles IMS Holdings, Inc. 2017 Incentive and Stock Award Plan (as amended from time to time, the “Plan”), which is incorporated herein by reference. Capitalized terms not defined in this Agreement shall have the meanings given to them in the Plan.
MANAGEMENT RIGHTS AGREEMENTLetter Agreement • February 15th, 2013 • Quintiles Transnational Holdings Inc. • New York
This letter agreement (this “Letter Agreement”) is being executed and delivered to confirm agreements with respect to the investment by 3i US Growth Healthcare Fund 2008 L.P. (the “Partnership”) in Quintiles Transnational Corp. (the “Company”) and certain management rights that the Company conferred upon the Partnership in connection with such investment so that investment may qualify as a “venture capital investment” within the meaning of the Department of Labor regulation Section 2510.3-101, as modified by Section 3(42) of ERISA (the “Plan Asset Regulation”).
amended and restated EMPLOYMENT AGREEMENTEmployment Agreement • February 19th, 2019 • Iqvia Holdings Inc. • Services-commercial physical & biological research • New York
AMENDED AND RESTATED EMPLOYMENT AGREEMENT, dated as of February 18, 2019 (the “Agreement”), between IQVIA Holdings Inc. (the “Company”) and Ari Bousbib (the “Executive”).
QUINTILES IMS HOLDINGS, INC. AWARD AGREEMENT (Awarding Restricted Stock Units)Award Agreement • May 8th, 2017 • Quintiles IMS Holdings, Inc. • Services-commercial physical & biological research • Delaware
THIS AWARD AGREEMENT (this “Agreement”) is made by and between Quintiles IMS Holdings, Inc., a Delaware corporation (the “Company”), and the Participant named above (the “Participant”) pursuant to the provisions of the Quintiles IMS Holdings, Inc. 2017 Incentive and Stock Award Plan (as amended from time to time, the “Plan”), which is incorporated herein by reference. Capitalized terms not defined in this Agreement shall have the meanings given to them in the Plan.
7,000,000 Shares QUINTILES TRANSNATIONAL HOLDINGS INC. COMMON STOCK (PAR VALUE $0.01 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • August 5th, 2015 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • New York
CONSULTING AND GENERAL RELEASE AGREEMENTSupplemental General Release Agreement • May 12th, 2014 • Quintiles Transnational Holdings Inc. • Services-commercial physical & biological research • North Carolina
This CONSULTING AND GENERAL RELEASE AGREEMENT (the “Consulting Agreement”) is made and entered into between Quintiles Transnational Corp. (the “Company”) and Michael Mortimer (the “Executive” or “Consultant” or “Executive/Consultant”). Throughout the remainder of the Consulting Agreement, the Company and Executive or Consultant may be collectively referred to as “the parties.”
SHARE REPURCHASE AGREEMENTShare Repurchase Agreement • February 24th, 2017 • Quintiles IMS Holdings, Inc. • Services-commercial physical & biological research
THIS SHARE REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of this 23rd day of February, 2017, by and among Quintiles IMS Holdings, Inc., a Delaware corporation (the “Purchaser”), and the selling shareholders set forth on Schedule I hereto (each, a “Seller” and, together, the “Sellers”).
AMENDMENT NO. 1 TO FOURTH AMENDED AND RESTATED CREDIT AGREEMENTCredit Agreement • March 8th, 2017 • Quintiles IMS Holdings, Inc. • Services-commercial physical & biological research • New York
AMENDMENT NO. 1, dated as of March 7, 2017 (this “Amendment”), among Quintiles IMS Incorporated, a Delaware corporation (the “Parent Borrower”), Quintiles IMS Holdings, Inc., a Delaware corporation, Bank of America, N.A., as administrative agent and as collateral agent (in such capacity, the “Administrative Agent”), the Lenders (as defined below) party hereto and the Incremental Term B-1 Euro Lenders (as defined below).
QUINTILES TRANSNATIONAL CORP. Riverbirch Building, Suite 200 Durham, NC 27703Quintiles Transnational Holdings Inc. • February 15th, 2013
This letter will confirm our agreement that pursuant to and effective as of your purchase of 1,840,000 shares of common stock (the “Shares”) of Quintiles Transnational Corp. (the “Company”), Aisling Capital II, L.P. (the “Investor”) shall be entitled to the following contractual management rights:
LOCK-UP LETTER May 3, 2016Quintiles Transnational Holdings Inc. • May 3rd, 2016 • Services-commercial physical & biological research
FIRST AMENDMENT TO AMENDED EXECUTIVE EMPLOYMENT AGREEMENTEmployment Agreement • February 15th, 2013 • Quintiles Transnational Holdings Inc.
This FIRST AMENDMENT TO AMENDED EXECUTIVE EMPLOYMENT AGREEMENT (“First Amendment”) is made and entered into as of the 30 day of December, 2008 by and between QUINTILES TRANSNATIONAL CORP., a North Carolina corporation (the “Company”), and DEREK WINSTANLY (“Executive”).
